Learning Management System

Skip Over Navigation

Course Description



TB-275a 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis


Enrollment DeadlineSectionCourse FormatStart/End Dates Details Instructor(s)Speakers
Enroll
Ongoing
Webinar Online Ongoing
Lisa Chen, MD   David Ashkin, MD   Richard Menzies, MD   Andrew Vernon, MD, MHS   Payam Nahid, MD, MPH   Susan E. Dorman, MD  


Course Description

This is the 1st webinar in a 2-part series.  This 90-minute webinar introduces the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and highlight the development process, the key changes in recommendations, and discuss the evidence supporting the changes. The didactic presentations will be followed by a discussion period with the ATS, CDC, and IDSA guidelines co-chairs.

Learning Objectives

Upon completion of this webinar, participants will be able to:

  • Understand the process and rationale for the recommendations in the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and use this information to guide clinical decision-making
  • Apply the new treatment guidelines in their own clinical practice, resulting in improved patient outcomes.

Webinar Materials:  https://www.currytbcenter.ucsf.edu/trainings/2016-atscdcidsa-clinical-practice-guidelines-treatment-drug-susceptible-tuberculosis/materials

 

 

Keywords:  TB, tuberculosis, TB disease, MTB, Mycobacterium tuberculosis, MTB complex

Prerequisites

Courses in this series are TB-275a and TB-275b.

Course Competencies

There are no competencies currently assigned to this course